Comments on: Novartis’ IND/MF drug achieves endpoints in Phase III study /news/novartis-combination-asthma-drug-phase-iii/ The leading site for news and procurement in the pharmaceutical industry Fri, 31 May 2019 10:39:47 +0000 hourly 1 https://wordpress.org/?v=6.6.2